Compare Stocks: RPID, QSI, QTRX, and CDXS

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CDXS Codexis	$1.36	$1.48	$0.96 ▼ $2.98	$148.93M	2.55	775,005 shs	551,867 shs
QSI Quantum-Si	$1.55 +8.4%	$0.81	$0.69 ▼ $3.10	$339.27M	3.21	4.74 million shs	18.69 million shs
QTRX Quanterix	$3.64 +6.7%	$3.05	$2.15 ▼ $8.77	$161.27M	1.01	892,274 shs	590,804 shs
RPID Rapid Micro Biosystems	$0.92 -0.1%	$1.50	$0.86 ▼ $4.94	$46.15M	1.5	340,627 shs	329,275 shs

The Best Nuclear Energy Stocks to Buy

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CDXS Codexis	0.00%	+3.03%	-7.80%	-44.94%	-45.60%
QSI Quantum-Si	+8.39%	+85.78%	+103.68%	+66.60%	+6.16%
QTRX Quanterix	+6.74%	+11.31%	+39.46%	-15.94%	-34.30%
RPID Rapid Micro Biosystems	-0.11%	-17.12%	-33.81%	-46.51%	-73.41%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CDXS Codexis	$1.36	$1.48	$0.96 ▼ $2.98	$148.93M	2.55	775,005 shs	551,867 shs
QSI Quantum-Si	$1.55 +8.4%	$0.81	$0.69 ▼ $3.10	$339.27M	3.21	4.74 million shs	18.69 million shs
QTRX Quanterix	$3.64 +6.7%	$3.05	$2.15 ▼ $8.77	$161.27M	1.01	892,274 shs	590,804 shs
RPID Rapid Micro Biosystems	$0.92 -0.1%	$1.50	$0.86 ▼ $4.94	$46.15M	1.5	340,627 shs	329,275 shs

The Best Nuclear Energy Stocks to Buy

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CDXS Codexis	0.00%	+3.03%	-7.80%	-44.94%	-45.60%
QSI Quantum-Si	+8.39%	+85.78%	+103.68%	+66.60%	+6.16%
QTRX Quanterix	+6.74%	+11.31%	+39.46%	-15.94%	-34.30%
RPID Rapid Micro Biosystems	-0.11%	-17.12%	-33.81%	-46.51%	-73.41%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CDXS Codexis	2.25	Hold	$6.50	377.94% Upside
QSI Quantum-Si	2.25	Hold	$2.50	61.29% Upside
QTRX Quanterix	1.67	Reduce	$3.00	-17.58% Downside
RPID Rapid Micro Biosystems	2.75	Moderate Buy	$5.00	443.48% Upside

Current Analyst Ratings Breakdown

Latest RPID, QSI, QTRX, and CDXS Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
9/29/2026	RPID Rapid Micro Biosystems	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$3.00
9/29/2026	QSI Quantum-Si	HC Wainwright Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$4.00
9/29/2026	RPID Rapid Micro Biosystems	Roth Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong-Buy
9/25/2026	CDXS Codexis	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
9/24/2026	QSI Quantum-Si	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
9/9/2026	QSI Quantum-Si	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
9/2/2026	CDXS Codexis	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/25/2026	QSI Quantum-Si	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
8/20/2026	CDXS Codexis	Benchmark Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Hold
8/17/2026	CDXS Codexis	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Overweight	$9.00 ➝ $8.00
8/17/2026	QTRX Quanterix	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Hold	$4.00 ➝ $3.00

(Data available from 10/3/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CDXS Codexis	$77.68M	1.92	N/A	N/A	$0.56 per share	2.43
QSI Quantum-Si	$1.61M	211.38	N/A	N/A	$1.02 per share	1.52
QTRX Quanterix	$153.17M	1.12	N/A	N/A	$6.33 per share	0.58
RPID Rapid Micro Biosystems	$33.59M	1.37	N/A	N/A	$0.75 per share	1.23

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CDXS Codexis	-$43.97M	-$0.34	N/A	N/A	N/A	-39.55%	-74.36%	-23.58%	11/5/2026 (Estimated)
QSI Quantum-Si	-$101.34M	-$0.46	N/A	N/A	N/A	-6,138.26%	-47.12%	-43.18%	11/4/2026 (Estimated)
QTRX Quanterix	-$107.15M	-$2.63	N/A	N/A	N/A	-80.25%	-26.09%	-19.03%	11/9/2026 (Estimated)
RPID Rapid Micro Biosystems	-$47.12M	-$1.12	N/A	N/A	N/A	-145.56%	-177.04%	-73.12%	11/6/2026 (Estimated)

Latest RPID, QSI, QTRX, and CDXS Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2026	Q2 2026	QSI Quantum-Si	-$0.1133	-$0.11	+$0.0033	-$0.11	$0.30 million	$0.34 million
8/11/2026	Q2 2026	CDXS Codexis	-$0.1417	-$0.13	+$0.0117	-$0.13	$13.82 million	$14.92 million
8/10/2026	Q2 2026	QTRX Quanterix	-$0.4103	-$1.04	-$0.6297	-$1.04	$37.48 million	$32.91 million
8/7/2026	Q2 2026	RPID Rapid Micro Biosystems	-$0.2433	-$0.27	-$0.0267	-$0.27	$7.88 million	$8.05 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
CDXS Codexis	N/A	N/A	N/A	N/A	N/A
QSI Quantum-Si	N/A	N/A	N/A	N/A	N/A
QTRX Quanterix	N/A	N/A	N/A	N/A	N/A
RPID Rapid Micro Biosystems	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CDXS Codexis	1.03	3.06	2.99
QSI Quantum-Si	N/A	9.97	9.80
QTRX Quanterix	N/A	3.40	2.45
RPID Rapid Micro Biosystems	1.08	2.55	1.51

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CDXS Codexis	78.54%
QSI Quantum-Si	39.90%
QTRX Quanterix	86.48%
RPID Rapid Micro Biosystems	52.60%

Insider Ownership

Company	Insider Ownership
CDXS Codexis	3.50%
QSI Quantum-Si	22.04%
QTRX Quanterix	1.50%
RPID Rapid Micro Biosystems	12.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CDXS Codexis	146	109.51 million	105.67 million	Optionable
QSI Quantum-Si	145	218.88 million	170.64 million	Optionable
QTRX Quanterix	450	47.29 million	46.58 million	Optionable
RPID Rapid Micro Biosystems	171	50.16 million	43.79 million	Not Optionable

RPID, QSI, QTRX, and CDXS Headlines

Recent News About These Companies

Rapid Micro Biosystems consensus price target cut by 13.75% to $5.86

October 2 at 3:13 PM | msn.com

Rapid Micro Biosystems (NASDAQ:RPID) Upgraded at Roth Capital

October 2 at 1:24 AM | americanbankingnews.com

Rapid Micro Biosystems (NASDAQ:RPID) Stock Moved Up to "Strong-Buy" by Roth Capital

September 30 at 8:11 AM | marketbeat.com

Rapid Micro Biosystems to Participate in Upcoming Investor Conferences

September 4, 2026 | globenewswire.com

After Plunging 33.7% in 4 Weeks, Here's Why the Trend Might Reverse for Rapid Micro Biosystems (RPID)

September 4, 2026 | zacks.com

Down 25.7% in 4 Weeks, Here's Why You Should You Buy the Dip in Rapid Micro Biosystems (RPID)

August 19, 2026 | zacks.com

Rapid Micro Biosystems (RPID) Upgraded to Buy: What Does It Mean for the Stock?

August 12, 2026 | zacks.com

Rapid Micro Biosystems, Inc. Q2 2026 Earnings Call Summary

August 8, 2026 | finance.yahoo.com

Rapid Micro Biosystems, Inc. (RPID) Reports Q2 Loss, Tops Revenue Estimates

August 7, 2026 | zacks.com

Rapid Micro Biosystems Reports Second Quarter 2026 Financial Results

August 7, 2026 | globenewswire.com

Rapid Micro Biosystems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 4, 2026 | globenewswire.com

Rapid Micro Biosystems to Announce Second Quarter 2026 Financial Results on August 7, 2026

July 23, 2026 | globenewswire.com

Rapid Micro Biosystems (RPID)

June 24, 2026 | zacks.com

Rapid Micro Biosystems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

June 10, 2026 | markets.businessinsider.com

Rapid Micro Biosystems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

June 10, 2026 | globenewswire.com

Rapid Micro Biosystems prices $9.8M capital raise with up to $21.7M in additional warrant potential

May 19, 2026 | msn.com

Rapid Micro Biosystems Announces Pricing of $9.8 Million Underwritten Public Offering of Class A Common Stock and Warrants

May 18, 2026 | quiverquant.comQ

Rapid Micro Biosystems Announces Pricing of Up to Approximately $32 Million Underwritten Offering

May 18, 2026 | globenewswire.com

Rapid Micro Biosystems Earnings Call Balances Growth And Risk

May 16, 2026 | theglobeandmail.com

Rapid Micro Biosystems Q1 2026 Earnings Call: Complete Transcript

May 14, 2026 | finance.yahoo.com

Rapid Micro Biosystems Inc (RPID) Q1 2026 Earnings Call Highlights: Strong Revenue Growth ...

May 14, 2026 | finance.yahoo.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

RPID, QSI, QTRX, and CDXS Company Descriptions

Codexis NASDAQ:CDXS

$1.36 0.00 (0.00%)

As of 10/2/2026 04:00 PM Eastern

Codexis, Inc. discovers, develops, and sells enzymes and other proteins. The company operates through two segments, Performance Enzymes and Novel Biotherapeutics. It offers biocatalyst products and services. The company also provides biocatalyst screening and protein engineering services. In addition, it offers CodeEvolver, a technology platform, which helps in developing and delivering biocatalysts that perform chemical transformations and enhance the efficiency and productivity of manufacturing processes. The company's platform is also used for molecular biology and in vitro diagnostic enzymes. It has a collaboration agreement with Nestlé Health Science to develop CDX-7108 for the treatment of exocrine pancreatic insufficiency. The company sells its products to pharmaceutical manufacturers through its direct sales and business development force in the United States and Europe. The company was incorporated in 2002 and is headquartered in Redwood City, California.

Quantum-Si NASDAQ:QSI

$1.55 +0.12 (+8.39%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$1.50 -0.05 (-3.55%)

As of 10/2/2026 07:58 PM Eastern

Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments. It is used in protein identification, protein variants, antibody characterization, biomarker identification, and post translational modification analysis applications. The company was founded in 2013 is headquartered in Branford, Connecticut.

Quanterix NASDAQ:QTRX

$3.64 +0.23 (+6.74%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$3.64 -0.01 (-0.14%)

As of 10/2/2026 07:58 PM Eastern

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

Rapid Micro Biosystems NASDAQ:RPID

$0.92 0.00 (-0.11%)

Closing price 10/2/2026 04:00 PM Eastern

Extended Trading

$0.92 +0.01 (+0.54%)

As of 10/2/2026 07:30 PM Eastern

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides onsite technical training services. Its solutions are used in environmental monitoring, water, bioburden, and sterility release testing applications. In addition, the company offers RMBNucleus software for the Growth Direct system; RMBNucleus Mold Alarm signals at the first sign of mold detection; RMBNucleus Central Manager portal streamlines coordination of multiple instruments; and Growth Direct LIMS connection software. Rapid Micro Biosystems, Inc. was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. The company was incorporated in 2006 and is headquartered in Lowell, Massachusetts.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest RPID, QSI, QTRX, and CDXS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest RPID, QSI, QTRX, and CDXS Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

RPID, QSI, QTRX, and CDXS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

RPID, QSI, QTRX, and CDXS Company Descriptions

Codexis NASDAQ:CDXS

Quantum-Si NASDAQ:QSI

Quanterix NASDAQ:QTRX

Rapid Micro Biosystems NASDAQ:RPID

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest RPID, QSI, QTRX, and CDXS Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest RPID, QSI, QTRX, and CDXS Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

RPID, QSI, QTRX, and CDXS Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

RPID, QSI, QTRX, and CDXS Company Descriptions

Codexis NASDAQ:CDXS

Quantum-Si NASDAQ:QSI

Quanterix NASDAQ:QTRX

Rapid Micro Biosystems NASDAQ:RPID

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools